Sunho Biologics (HKG:2898) said Yin Liusong stepped down as the company's chief executive and chief scientific officer to pursue opportunities elsewhere, according to a Hong Kong bourse filing Monday.
Shares of the biologics firm fell nearly 1% in morning trade Tuesday.
Yin's last working day will be Feb. 28.